FibroGen, Inc. (NASDAQ:FGEN) Receives $24.83 Consensus PT from Analysts
FibroGen, Inc. (NASDAQ:FGEN – Get Rating) has earned a consensus rating of “Hold” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating on the company. The average […]